Imagine a country where hospitals are running out of essential medicines, despite a record-breaking budget allocation for healthcare. This is the stark reality in Papua New Guinea, where a recent parliamentary report exposes a systemic failure that’s putting lives at risk. Prime Minister James Marape has taken a bold stand, putting the Health Department and Provincial Health Authorities on notice as drug shortages persist across the nation.
But here’s where it gets controversial: despite a historic K500 million earmarked for medicinal products in the 2026 National Budget, the crisis continues. Is it a funding issue, or is something far more insidious at play? Mr. Marape insists the problem isn’t money but a fragmented distribution system and weak management at both national and provincial levels. This echoes the findings of a 2020 inquiry by the Permanent Parliamentary Committee on Public Accounts, which slammed the Health Department for its failure to manage logistics and distribution effectively.
The report highlights a critical issue often overlooked: the last-mile delivery—the final stretch between medical stores and clinics—is the weakest link in the supply chain. This vulnerability exposes medicines to theft, damage from poor handling, and loss, particularly in remote areas. And this is the part most people miss: even when medicines arrive in the country, logistical hurdles often prevent them from reaching those who need them most.
Financial mismanagement adds another layer to this crisis. The inquiry uncovered massive backlogs of unpaid bills, with the Department of Health owing K73 million to a single contractor, including K40 million outstanding since 2017. Such delays discourage suppliers, further exacerbating shortages. Moreover, the report raises red flags about governance, suggesting a risk of corruption and a lack of transparency within the Medicine Supplies and Distribution Procurement Branch.
Public tenders for medical supplies, for instance, are described as slow and poorly planned, with some contracts taking nearly a year to finalize. Mr. Marape’s intervention aims to tackle these bottlenecks by streamlining approvals and relaxing rigid rules that hinder medicine flow. Yet, despite each of the 22 Provincial Health Authorities receiving at least K10 million annually over the past four years, many health workers lack training in inventory management. This gap forces clinics to rely on estimates when ordering medicines, leading to inefficiencies.
Is transparency the missing piece of the puzzle? The report demands it, arguing that the government’s failure to create a transparent environment has allowed systemic issues to fester. But here’s a thought-provoking question: Could the root of the problem lie in deeper structural issues within the healthcare system, rather than just mismanagement? We’d love to hear your thoughts in the comments—do you think this crisis is a result of poor governance, systemic flaws, or something else entirely?
